Epigenetic basis of cancer drug resistance

被引:12
作者
Aziz, Moammir H. [1 ]
Ahmad, Aamir [2 ]
机构
[1] James H Quillen VA Med Ctr, Johnson City, TN 37604 USA
[2] Univ Alabama Birmingham, Sch Med, 901 19th St S,370 BMRII, Birmingham, AL 35205 USA
关键词
D O I
10.20517/cdr.2020.06
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:113 / 116
页数:4
相关论文
共 23 条
[1]   Cancer Epigenetics: Clinical Perspectives [J].
Ahmad, Aamir .
CURRENT CANCER DRUG TARGETS, 2019, 19 (07) :513-514
[2]   Cancer Epigenetics [J].
Ahmad, Aamir .
CURRENT CANCER DRUG TARGETS, 2018, 18 (01) :3-4
[3]   Epigenetics in Personalized Management of Lung Cancer [J].
Ahmad, Aamir .
LUNG CANCER AND PERSONALIZED MEDICINE: NOVEL THERAPIES AND CLINICAL MANAGEMENT, 2016, 890 :111-122
[4]   Epigenetic regulation of miRNA-cancer stem cells nexus by nutraceuticals [J].
Ahmad, Aamir ;
Li, Yiwei ;
Bao, Bin ;
Kong, Dejuan ;
Sarkar, Fazlul H. .
MOLECULAR NUTRITION & FOOD RESEARCH, 2014, 58 (01) :79-86
[5]   Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs [J].
Ahmad, Aamir ;
Maitah, Ma'in Y. ;
Ginnebaugh, Kevin R. ;
Li, Yiwei ;
Bao, Bin ;
Gadgeel, Shirish M. ;
Sarkar, Fazlul H. .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
[6]   Alkylating anticancer agents and their relations to microRNAs [J].
Biersack, Bernhard .
CANCER DRUG RESISTANCE, 2019, 2 (01) :1-17
[7]   Targeting miRNAs by histone deacetylase inhibitors (HDACi): Rationalizing epigenetics-based therapies for breast cancer [J].
Ediriweera, Meran Keshawa ;
Cho, Somi Kim .
PHARMACOLOGY & THERAPEUTICS, 2020, 206
[8]   Tumor Immunology and Tumor Evolution: Intertwined Histories [J].
Galon, Jerome ;
Bruni, Daniela .
IMMUNITY, 2020, 52 (01) :55-81
[9]   Towards personalized treatment for early stage HER2-positive breast cancer [J].
Goutsouliak, Kristina ;
Veeraraghavan, Jamunarani ;
Sethunath, Vidyalakshmi ;
De Angelis, Carmine ;
Osborne, C. Kent ;
Rimawi, Mothaffar F. ;
Schiff, Rachel .
NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (04) :233-250
[10]   The Role of Histone Protein Modifications and Mutations in Histone Modifiers in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia [J].
Janczar, Szymon ;
Janczar, Karolina ;
Pastorczak, Agata ;
Harb, Hani ;
Paige, Adam J. W. ;
Zalewska-Szewczyk, Beata ;
Danilewicz, Marian ;
Mlynarski, Wojciech .
CANCERS, 2017, 9 (01)